BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 30

• Genetown

  Shire To Participate At The Piper Jaffray 27th Annual Healthcare Conference

  November 24, 2015

   · 

  1 min read
• Pharm Country

  Bayer Release: Physician Survey Demonstrates Need For Greater Awareness Of Rare, Life-Threatening Lung Condition

  November 24, 2015

   · 

  4 min read
• BioMidwest

  Lipocine Inc. To Present At 27th Annual Piper Jaffray Healthcare Conference

  November 24, 2015

   · 

  1 min read
• German Biotechnology Organization Release: The Deal Environment Is Active But Selective Experts Discuss Partnerships Between Pharma And Biotech

  November 24, 2015

   · 

  2 min read
• FDA

  Swedish Orphan Biovitrum And Biogen’s ELOCTA (rFVIIIFc) Approved In Europe For The Treatment Of Haemophilia A

  November 24, 2015

   · 

  7 min read
• Pharm Country

  European Commission (EC) Approves Reconciliation Of Indications For Nivolumab Under The Opdivo European Marketing Authorization Application

  November 24, 2015

   · 

  1 min read
• FDA

  Bristol-Myers Squibb Announces U.S. FDA Approval For Opdivo (Nivolumab) As A Single Agent For The Treatment Of Patients With Previously Untreated BRAF Wild-Type Advanced Melanoma

  November 24, 2015

   · 

  1 min read
• FDA

  Bristol-Myers Squibb Receives FDA Approval For Opdivo (Nivolumab), The Only Treatment To Deliver Significant Overall Survival In Advanced Renal Cell Carcinoma Vs. A Standard Of Care, In Patients Who Have Received Prior Anti-Angiogenic Therapy1

  November 24, 2015

   · 

  1 min read
• Deals

  Pivot Pharmaceuticals Completes Acquisition Of Indus Pharma

  November 24, 2015

   · 

  4 min read
• BioCapital

  CapGenesis Announces Start Of Dosing In An Exploratory Study Of CGS-125 For Management Of Osteoarthritic Knee Pain

  November 24, 2015

   · 

  3 min read